Equine rhinitis viruses: An overlooked cause of respiratory infection (Sponsored by Boehringer Ingelheim Vetmedica Inc.)

Medicus Pharma submitted a product development plan to the FDA for an Investigational New Animal Drug designation.

Marcy Bliss, CEO of Wedgewood Pharmacy, talks GFI #256 compliance and how drug compounding has changed over time

As equine veterinarians and advocates work to ensure their patient-athletes are receiving proper care, scientists work to advance therapies and better understand their physiology

In this episode of The Vet Blast Podcast, Jove Jacob shares with Dr Adam Christman about what veterinary school is like in his country, plus discusses his interests in the field and more.

The new guidelines will address 2 viral causes of liver damage impact equine patients

Approved by the FDA in January 2024, EquiCoxib is a noninvasive, liquid formulation.